Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
05/30/2007 | EP1789406A1 Thioxothiazolidinone compounds for use as pharmaceuticals |
05/30/2007 | EP1789054A2 Cannabinoid compositions and methods of use thereof |
05/30/2007 | EP1789034A1 Compounds with diphenoyl -structure for the treatment of immune diseases |
05/30/2007 | EP1562940B1 Aryl sulfonamides |
05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
05/30/2007 | EP1385527B1 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof |
05/30/2007 | EP1373220B1 Benzimidazoles that are useful in treating sexual dysfunction |
05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
05/30/2007 | EP1311663B1 Claudin polypeptides |
05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
05/30/2007 | CN1972946A 7h-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent |
05/30/2007 | CN1972701A Appetite-suppressing compositions and methods |
05/30/2007 | CN1972690A Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases |
05/30/2007 | CN1972689A Solid orally ingestible formulations of tetrodotoxin |
05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |
05/30/2007 | CN1970546A Naproxen-2-aryl morpholine ethyl ester and its preparation method and uses |
05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
05/30/2007 | CN1970073A Chinese medicinal composition for treating pain and preparation process thereof |
05/30/2007 | CN1970071A Preparation method of minipills of 'Xiao Chai Hu' |
05/30/2007 | CN1970057A Medicament for treating rheumatism |
05/30/2007 | CN1970045A Externally applied Chinese medicine for treating cervical and lumbar spondylosis |
05/30/2007 | CN1970044A Medicinal composition for treating rheumatoid arthritis and method for preparing same |
05/30/2007 | CN1970030A Chinese medicine for treating rheumatoid arthritis, preparation method and application thereof |
05/30/2007 | CN1970016A Medicated wine for treating strain and contusion |
05/30/2007 | CN1970011A Medicated wine for treating toothache |
05/30/2007 | CN1969993A Externally applied medicament for dispelling wind, scattering cold, unblocking collaterals and stopping pain and preparation process thereof |
05/30/2007 | CN1969989A Capsule for unblocking collaterals to treat arthritis |
05/30/2007 | CN1969974A Medicated wine for treating traumatic injury |
05/30/2007 | CN1969972A Chinese medicinal powder for treating rheumatic disease |
05/30/2007 | CN1969971A Transdermal absorption formulation of total alkaloid of common monkshood root and preparation process thereof |
05/30/2007 | CN1969969A Ointment for relieving pain and diminishing swelling and preparation process thereof |
05/30/2007 | CN1969956A Extract of Kadsura longepedunculata Finet et Gagnep, preparation process and use thereof |
05/30/2007 | CN1969929A Dry coating sustained-release tablet for treating arthritis and preparation process thereof |
05/30/2007 | CN1969928A Enteric coated/sustained release formulation of triperygium wilfordii and preparation process thereof |
05/30/2007 | CN1969909A Pharmaceutical composition for treating traumatic injury |
05/30/2007 | CN1969887A Method for extracting propolis functional ingredient by using microwave technology |
05/30/2007 | CN1969850A Taste masked suspension prescription for treating infant cold and method for preparing same |
05/30/2007 | CN1969841A Herbal extract for treating rheumatoid arthritis |
05/30/2007 | CN1969835A Carboxyl contained NSAIDS (nonsteroidal anti-inflammatory drugs) salt |
05/30/2007 | CN1969815A Sustained release agent of curcumin and preparation method thereof |
05/30/2007 | CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
05/30/2007 | CN1318404C Aryl ureas as kinase inhibitors |
05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
05/30/2007 | CN1318089C Use of botulinum toxin for treatment of articular pathologies |
05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
05/30/2007 | CN1318085C Ossotide injection and preparation method thereof |
05/30/2007 | CN1318084C Neuroprotective peptides |
05/30/2007 | CN1318081C Ant oil liniment and its preparing method |
05/30/2007 | CN1318076C Bone numbness releasing medicine |
05/30/2007 | CN1318053C Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method |
05/30/2007 | CN1318043C Bupleurum oily emulsion injection liquid and its production method |
05/30/2007 | CN1318021C Rapidly disintegrating table and process for manufacture thereof |
05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
05/29/2007 | US7223858 Truncated aggrecanase molecules |
05/29/2007 | US7223846 Urocortin proteins and uses thereof |
05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
05/29/2007 | US7223837 Anticancer prodrugs, enhance enzymatic activation rates |
05/29/2007 | US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents |
05/29/2007 | US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |
05/29/2007 | US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
05/29/2007 | US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example |
05/29/2007 | US7223760 Substituted triazole compounds |
05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
05/29/2007 | US7223394 Human antibodies that bind human TNFα |
05/29/2007 | US7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
05/29/2007 | CA2336732C Topical plaster with non-steroidal antirheumatic agents with an acid group |
05/24/2007 | WO2007059219A1 Azaindazoles useful as inhibitors of kinases |
05/24/2007 | WO2007058894A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
05/24/2007 | WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE |
05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
05/24/2007 | WO2007057714A2 Pharmaceutical compositions comprising methotrexate |
05/24/2007 | WO2007057691A2 Therapeutic uses of steroidal compounds |
05/24/2007 | WO2007057221A2 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases |
05/24/2007 | US20070117842 Polymorph of 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6- quinolinecarboxamide and a process for the preparation of the same |
05/24/2007 | US20070117820 1-([3-Chloro-5-trifluoromethylpyridinyl-2-yl]piperidin-4-yl)-3-(1-methyl-isoquinolin--5-yl)-urea hydrochloride; capsaicin receptor antagonist; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, neuralgia, migraine, neuropathies, diabetic neuropathy |
05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
05/24/2007 | US20070117788 Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases |
05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
05/24/2007 | US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules |
05/24/2007 | US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
05/24/2007 | US20070117160 Novel method of screening |
05/24/2007 | US20070117154 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |